These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 2424113)

  • 1. [Comparative study of the effectiveness of 2 methods of specific immunotherapy of pollinoses].
    Polsacheva OV; Gushchin IS; Poroshina IuA; Chitaeva VG; Shustova VI
    Ter Arkh; 1986; 58(4):120-3. PubMed ID: 2424113
    [No Abstract]   [Full Text] [Related]  

  • 2. Rush immunotherapy with sublingual administration of grass allergen extract.
    Feliziani V; Marfisi RM; Parmiani S
    Allergol Immunopathol (Madr); 1993; 21(5):173-8. PubMed ID: 8160561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose sublingual immunotherapy in children at 8-year follow-up.
    Leonardi S; Spicuzza L; La Rosa M
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):259-60. PubMed ID: 19354077
    [No Abstract]   [Full Text] [Related]  

  • 4. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
    Roberts G; Hurley C; Turcanu V; Lack G
    J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of E.P.D., a new immunotherapy, in the treatment of allergic diseases in children.
    Caramia G; Franceschini F; Cimarelli ZA; Ciucchi MS; Gagliardini R; Ruffini E
    Allerg Immunol (Paris); 1996 Nov; 28(9):308-10. PubMed ID: 8986246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
    Ariano R; Panzani RC; Mistrello G
    Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaccination with allergens in children].
    Demoly P; Dhivert-Donnadieu H; Bousquet J
    Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pollen-induced allergy. Programming and monitoring of specific immunotherapy].
    Obtułowicz K
    Folia Med Cracov; 1988; 29(1-2):21-48. PubMed ID: 3255656
    [No Abstract]   [Full Text] [Related]  

  • 9. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experiences with desensitization of early spring pollen allergy using 2 tree pollen extracts].
    Henzgen M; Wenz W; Strümpfel R
    Z Gesamte Inn Med; 1989 Nov; 44(22):691-3. PubMed ID: 2626850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epicutaneous allergen administration: a novel approach for allergen-specific immunotherapy?
    Werfel T
    J Allergy Clin Immunol; 2009 Nov; 124(5):1003-4. PubMed ID: 19895988
    [No Abstract]   [Full Text] [Related]  

  • 12. Accelerated Up-Dosing of Subcutaneous Immunotherapy with a Registered Allergoid Birch Pollen Preparation.
    Buczyłko K; van der Werf JF; Boot D; van Ree R
    Int Arch Allergy Immunol; 2017; 172(3):183-186. PubMed ID: 28380494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allergic rhinoconjunctivitis and immunotherapy: an update].
    Leimgruber A; Spertini F
    Rev Med Suisse; 2009 Jan; 5(186):88-93. PubMed ID: 19238924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, placebo-controlled study of preventive immunotherapy with E.P.D., in the treatment of seasonal allergic disease.
    Di Stanislao C; Di Berardino L; Bianchi I; Bologna G
    Allerg Immunol (Paris); 1997 Feb; 29(2):39-42. PubMed ID: 9084819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rush sublingual immunotherapy in Parietaria allergic patients.
    D'Ambrosio FP; Ricciardi L; Isola S; Savi E; Parmiani S; Puccinelli P; Musarra A
    Allergol Immunopathol (Madr); 1996; 24(4):146-51. PubMed ID: 8939269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on specific immunotherapy with the aid of 3M Diagnostic Systems' tests.
    Stasiak-Barmuta A; Dabrowska I; Piotrowska T; Hofman J
    Pneumonol Alergol Pol; 1992; 60 Suppl 1():53-6. PubMed ID: 1292848
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
    Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of sublingual immunotherapy in children.
    Bufe A
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():61-3. PubMed ID: 19221622
    [No Abstract]   [Full Text] [Related]  

  • 19. [Desensitization by the extemporaneous combination of aluminum hydroxide with allergens (delayed-action allergens)].
    Wolfromm R; Vallery-Radot C; Guibert L; Zalman Z
    Acta Allergol; 1969 Sep; 24(3):202-15. PubMed ID: 5395957
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring of various types of immunotherapy with gramineal pollens. II. Variation of humoral immunochemical parameters.
    Miguel Lozano R; Guerra Pasadas F; Arenas Vacas A; Daza Muñoz JC; Torres Murillo P; Sánchez Guijo P
    Allergol Immunopathol (Madr); 1992; 20(6):235-9. PubMed ID: 1296465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.